{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:53:29Z","timestamp":1789980809543,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T00:00:00Z","timestamp":1372204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00259-013-2478-8","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T07:35:53Z","timestamp":1372145753000},"page":"1567-1572","source":"Crossref","is-referenced-by-count":49,"title":["[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment"],"prefix":"10.1007","volume":"40","author":[{"given":"A.","family":"Br\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Virta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Koikkalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Helenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"N\u00e5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Parkkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Viitanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. O.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,26]]},"reference":[{"key":"2478_CR1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303\u20138.","journal-title":"Arch Neurol"},{"key":"2478_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","volume":"75","author":"SM Landau","year":"2010","unstructured":"Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010;75:230\u20138.","journal-title":"Neurology"},{"key":"2478_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1212\/01.wnl.0000287091.57376.65","volume":"70","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008;70:191\u20139.","journal-title":"Neurology"},{"key":"2478_CR4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","volume":"52","author":"CR Jack Jr","year":"1999","unstructured":"Jack Jr CR, Petersen RC, Xu YC, O\u2019Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397\u2013403.","journal-title":"Neurology"},{"key":"2478_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000133114.92694.93","volume":"63","author":"ES Korf","year":"2004","unstructured":"Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology. 2004;63:94\u2013100.","journal-title":"Neurology"},{"key":"2478_CR6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging. 2003;30:1104\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2478_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5:228\u201334.","journal-title":"Lancet Neurol"},{"key":"2478_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385\u201393.","journal-title":"JAMA"},{"key":"2478_CR9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","volume":"68","author":"NM Kemppainen","year":"2007","unstructured":"Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology. 2007;68:1603\u20136.","journal-title":"Neurology"},{"key":"2478_CR10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","volume":"73","author":"A Okello","year":"2009","unstructured":"Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Nagren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73:754\u201360.","journal-title":"Neurology"},{"key":"2478_CR11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","volume":"76","author":"J Koivunen","year":"2011","unstructured":"Koivunen J, Scheinin N, Virta JR, Aalto S, Vahlberg T, Nagren K, et al. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology. 2011;76:1085\u201390.","journal-title":"Neurology"},{"key":"2478_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroimage.2011.01.062","volume":"56","author":"J L\u00f6tj\u00f6nen","year":"2011","unstructured":"L\u00f6tj\u00f6nen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, et al. Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer\u2019s disease. Neuroimage. 2011;56:185\u201396.","journal-title":"Neuroimage"},{"key":"2478_CR13","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.neuroimage.2009.10.026","volume":"49","author":"JM L\u00f6tj\u00f6nen","year":"2010","unstructured":"L\u00f6tj\u00f6nen JM, Wolz R, Koikkalainen JR, Thurfjell L, Waldemar G, Soininen H, et al. Fast and robust multi-atlas segmentation of brain magnetic resonance images. Neuroimage. 2010;49:2352\u201365.","journal-title":"Neuroimage"},{"key":"2478_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.21904","volume":"67","author":"DM Rentz","year":"2010","unstructured":"Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010;67:353\u201364.","journal-title":"Ann Neurol"},{"key":"2478_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.21212","volume":"63","author":"NM Kemppainen","year":"2008","unstructured":"Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer\u2019s disease. Ann Neurol. 2008;63:112\u20138.","journal-title":"Ann Neurol"},{"key":"2478_CR16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","volume":"66","author":"JC Morris","year":"2009","unstructured":"Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol. 2009;66:1469\u201375.","journal-title":"Arch Neurol"},{"key":"2478_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67:122\u201331.","journal-title":"Ann Neurol"},{"key":"2478_CR18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hbm.20905","volume":"31","author":"LG Apostolova","year":"2010","unstructured":"Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack Jr CR, et al. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp. 2010;31:786\u201397.","journal-title":"Hum Brain Mapp"},{"key":"2478_CR19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","volume":"68","author":"DP Devanand","year":"2007","unstructured":"Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology. 2007;68:828\u201336.","journal-title":"Neurology"},{"key":"2478_CR20","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain. 2007;130:2837\u201344.","journal-title":"Brain"},{"key":"2478_CR21","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, et al. Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain. 2006;129:2856\u201366.","journal-title":"Brain"},{"key":"2478_CR22","doi-asserted-by":"crossref","first-page":"198.e1","DOI":"10.1016\/j.neurobiolaging.2010.06.015","volume":"33","author":"A Kadir","year":"2012","unstructured":"Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Langstrom B, et al. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:198.e1\u201314.","journal-title":"Neurobiol Aging"},{"key":"2478_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","volume":"9","author":"JO Rinne","year":"2010","unstructured":"Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer\u2019s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol. 2010;9:363\u201372.","journal-title":"Lancet Neurol"},{"key":"2478_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Chetelat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181\u201392.","journal-title":"Ann Neurol"},{"key":"2478_CR25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.0b013e3181bacf1b","volume":"73","author":"NM Scheinin","year":"2009","unstructured":"Scheinin NM, Aalto S, Koikkalainen J, L\u00f6tj\u00f6nen J, Karrasch M, Kemppainen N, et al. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology. 2009;73:1186\u201392.","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2478-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T18:48:31Z","timestamp":1715539711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,26]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2478"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2478-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,26]]}}}